Skip to main content

Table 1 Demographic characteristics of systemic lupus erythematosus patients

From: The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus

Patient

Sex

Age (years)

ECLAM score

Medication

1

Female

25

1.5

HQ,P

2

Female

25

0.5

0

3

Female

52

2.5

0

4

Female

24

1.5

C,P

5

Female

29

0

HQ

6

Female

43

1

0

7

Female

29

0.5

HQ,P

8

Female

38

1.5

HQ,Aza,P

9

Female

34

0

MTX,P

10

Female

60

0

MTX,P

11

Female

52

1

P

12

Female

48

2

HQ,P

13

Female

43

0

0

14

Female

62

1

HQ,P

15

Male

33

0

HQ

16

Female

34

2

Aza,P

17

Female

37

3

0

18

Male

30

0

Ara,P

19

Female

45

4

0

20

Female

31

1

0

21

Female

24

6

Aza,P

22

Female

30

1

0

23

Female

29

1.5

MTX,HQ

24

Female

49

2

0

25

Female

28

2

HQ

26

Female

24

1.5

P

27

Male

45

1

HQ,P

28

Female

22

3.5

HQ,P

29

Female

26

0

HQ

30

Female

29

1

P

31

Female

24

2

0

32

Female

61

2

P

33

Female

43

5.5

MTX,P

34

Female

33

1

0

35

Male

44

1

C

  1. 0, none; Aza, azathioprin; C, cyclophosphamide; ECLAM, European Consensus Lupus Activity Measurement; HQ, hydroxychloroquine; MTX, metothrexate; P, prednisolone.